AmebaGone is developing proprietary technologies uses novel biocontrol method to destroy intractable bacterial infections.
AmebaGone Inc. will solve one of the 21st century’s most compelling problems -- that of growing antibiotic resistance alongside a dwindling supply of effective antimicrobial products. Antibiotic resistance is a worldwide problem that manifests itself in agriculture, medicine, and industry. And while the threat of infectious disease is intensifying, the discovery of new antibiotics has slowed dramatically. Pharmaceutical companies have largely abandoned the discovery of new antibiotics, despite the likelihood of an impending health crisis.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 4, 2015 | Grant | $0.90M | 1 | National Science Foundation | — | Detail |
Dec 6, 2013 | Grant | $149.24K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |